Application of hsa-mir-145-5p in the treatment of breast cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- TSINGHUA BERKELEY SHENZHEN INST
- Publication Date
- 2021-04-20
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biotechnology and relates to tumor molecular markers, in particular to the application of hsa-miR-145-5p in treating breast cancer and improving the sensitivity of breast cancer to therapeutic drugs. Background technique
[0002] The latest global statistical analysis of tumors in 2018 covers 185 countries and regions and 36 types of cancer. It mainly analyzes the incidence and mortality of each cancer in 2018, as well as the incidence of tumors in various regions. Statistics show that so far, there are about 18.19 million new cancer cases and 9.6 million cancer deaths worldwide. Asia accounts for about 50% of new cancer cases and 70% of cancer deaths. The final analysis results show that breast cancer is the number one "killer" of women (globally, there will be about 2.1 million newly diagnosed female breast cancer cases in 2018), and among the diagnosed female cancer cases worldwide, breast cancer Accounting for...